InsiderTrades

Form 4/A for IART INTEGRA LIFESCIENCES HOLDINGS CORP

Accepted 2023-10-13 00:00:00 ET · period of report 2023-03-10 · accession 0001209191-23-052775 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2023-10-13 2023-03-11 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 +205 5,211 +4% $0
DA 2023-10-13 2023-03-11 IART De Witte Jan Pres, CEO, Dir F - Tax $52.87 -205 5,006 -4% -$10.8K
DA 2023-10-13 2023-03-11 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 -205 99.8K -0.2% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-11 M A 205 $0.00 5,211 D — — (F1) This transaction was inadvertently omitted from the Reporting Person's Form 4 filed on March 14, 2023.
2 Common Common Stock 2023-03-11 F D 205 $52.87 5,006 D — — (F1) This transaction was inadvertently omitted from the Reporting Person's Form 4 filed on March 14, 2023.
3 Derivative Restricted Stock Units 2023-03-11 M D 205 $0.00 99,828 D $0.00 · — to — 205 Common Stock (F1) This transaction was inadvertently omitted from the Reporting Person's Form 4 filed on March 14, 2023. (F2) The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2022 which shall be delivered to the Reporting Person within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.